ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Operating cash flow minus capital expenditures
Percentile
P21
Within normal range
vs 5Y Ago
-1.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-1.31B | -314.0% |
| 2024 | $611.77M | +191.9% |
| 2023 | $-665.75M | -185.3% |
| 2022 | $780.71M | +239.7% |
| 2021 | $229.82M | -70.0% |
| 2020 | $765.61M | +1318.4% |
| 2019 | $53.98M | +81.7% |
| 2018 | $29.70M | -99.2% |
| 2017 | $3.92B | +86.2% |
| 2016 | $2.11B | - |